NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE

Your AI-Trained Oncology Knowledge Connection!

This roundtable series reviews treatment after progression for patients with advanced melanoma, as discussed by key opinion leaders at virtual live events and interviews.

Later-Line Therapies Used in Unresectable or Metastic Melanoma

$Considering Lifileucel for PD-1–Refractory Advanced Melanoma$

Considering Lifileucel for PD-1–Refractory Advanced Melanoma

September 30, 2025

During a live event, Michael C. Lowe, MD, MA, discussed how lifileucel provides an option for patients with unresectable or metastatic melanoma.

Lifileucel Offers Promising Long-Term Efficacy in Advanced Melanoma

Lifileucel Offers Promising Long-Term Efficacy in Advanced Melanoma

August 05, 2025

During a live event, Barbara T. Ma, MD, MS, examined trial data on lifileucel tumor infiltrating lymphocyte therapy in patients with advanced melanoma.

Awareness of TIL Therapy for Melanoma Is Crucial for Timely Referral

Awareness of TIL Therapy for Melanoma Is Crucial for Timely Referral

During a live event, Barbara T. Ma, MD, MS, reviewed guidelines on management and best practices for the use of tumor-infiltrating lymphocytes in melanoma.

Behind the C-144-01 Study of Lifileucel in Melanoma

Behind the C-144-01 Study of Lifileucel in Melanoma

Theresa Medina, MD, discusses treatment with lifileucel in patients with advanced melanoma and the background of the C-144-01 study.

© 2025 MJH Life Sciences^®

All rights reserved.